BRCA2 and ovarian cancer: Germline TP53 mutations have been reported in rare instances of hereditary breast cancer (HBC) and hereditary breast and ovarian cancer (HBOC) syndrome families found negative for mutations in the BRCA1 and BRCA2 breast and ovarian cancer susceptibility genes.